ClinicalTrials.Veeva

Menu

Preimplant Site Augmentation Using MPM Versus Autogenous Bone Graft

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Bone Resorption

Treatments

Other: Autogenous bone graft (gold standard).
Other: Mineralized plasmatic matrix (MPM).

Study type

Interventional

Funder types

Other

Identifiers

NCT03007069
CairoMPM-ABG

Details and patient eligibility

About

Using growth factors obtained from patient's venous blood mixed with particulate autogenous bone the study compares bone gain by implant with gold standards.

Full description

To study the effectiveness of MPM in ridge augmentation with implant insertion compared with autogenous bone graft.

-PICO-

Population (P): Patients with defective maxillary alveolar ridge requiring implant insertion.

Intervention (I): Ridge augmentation with MPM.

Comparator (C): Autogenous bone graft.

Outcome (O): Patient satisfaction - Implant stability.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Medically free patients.
  2. Evaluated bone height on CBCT to be (0-4 mm buccal bone dehiscence) and width (not less than 4.5 mm)
  3. Patients with Anterior maxillary defective partially edentulous ridge.
  4. Age between 18 and 40 years.
  5. Both sexes.
  6. Patients physically able to tolerate surgical and restorative procedures.
  7. Patients with an opposing tooth to the pre-implant site.
  8. Good oral hygiene.
  9. Highly motivated patients.

Exclusion criteria

  1. Patients allergic to local anesthetic agent.
  2. Pregnant or lactating females.
  3. Presence of any pathosis in the pre-implant site.
  4. Presence of any mucosal disease.
  5. Presence of parafunctional habits.
  6. History of oral radiotherapy.
  7. History of prolonged steroids use.
  8. Psychological disorders.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 2 patient groups

Autogenous bone graft (Gold Standard).
Experimental group
Description:
Patients with defective maxillary alveolar ridges requiring implant insertion will have Autogenous bone graft (Gold standard) and collagen membrane to be used for bone augmentation around exposed threads of inserted dental implants.
Treatment:
Other: Autogenous bone graft (gold standard).
MPM Augmentation.
Active Comparator group
Description:
Mineralized plasmatic matrix (MPM) to be used without collagen membrane to augment the defect in the maxillary bone and cover the exposed threads of the dental implants.
Treatment:
Other: Mineralized plasmatic matrix (MPM).

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems